NASDAQ:LAKE

Lakeland Industries Competitors

$28.08
-0.05 (-0.18 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$27.83
Now: $28.08
$28.24
50-Day Range
$26.53
MA: $29.87
$36.27
52-Week Range
$12.44
Now: $28.08
$47.95
Volume104,115 shs
Average Volume313,636 shs
Market Capitalization$225.20 million
P/E Ratio7.98
Dividend YieldN/A
Beta0.03

Competitors

Lakeland Industries (NASDAQ:LAKE) Vs. SIEN, IVC, SMTI, SRGA, SRGA, and CFMS

Should you be buying LAKE stock or one of its competitors? Companies in the industry of "surgical appliances & supplies" are considered alternatives and competitors to Lakeland Industries, including Sientra (SIEN), Invacare (IVC), Sanara MedTech (SMTI), Surgalign (SRGA), Surgalign (SRGA), and Conformis (CFMS).

Sientra (NASDAQ:SIEN) and Lakeland Industries (NASDAQ:LAKE) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk.

Analyst Recommendations

This is a summary of current recommendations and price targets for Sientra and Lakeland Industries, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Sientra00403.00
Lakeland Industries00203.00

Sientra currently has a consensus price target of $10.00, indicating a potential upside of 39.47%. Lakeland Industries has a consensus price target of $31.3333, indicating a potential upside of 11.59%. Given Sientra's higher probable upside, analysts plainly believe Sientra is more favorable than Lakeland Industries.

Profitability

This table compares Sientra and Lakeland Industries' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Sientra-123.88%-174.05%-38.97%
Lakeland Industries18.93%28.75%24.67%

Volatility & Risk

Sientra has a beta of 1.81, suggesting that its stock price is 81% more volatile than the S&P 500. Comparatively, Lakeland Industries has a beta of 0.03, suggesting that its stock price is 97% less volatile than the S&P 500.

Insider & Institutional Ownership

71.0% of Sientra shares are held by institutional investors. Comparatively, 70.8% of Lakeland Industries shares are held by institutional investors. 2.8% of Sientra shares are held by insiders. Comparatively, 4.9% of Lakeland Industries shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Sientra and Lakeland Industries' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sientra$83.70 million4.91$-106,820,000.00($2.29)-3.13
Lakeland Industries$107.81 million2.09$3.28 million$0.4562.40

Lakeland Industries has higher revenue and earnings than Sientra. Sientra is trading at a lower price-to-earnings ratio than Lakeland Industries, indicating that it is currently the more affordable of the two stocks.

Summary

Lakeland Industries beats Sientra on 8 of the 13 factors compared between the two stocks.

Lakeland Industries (NASDAQ:LAKE) and Invacare (NYSE:IVC) are both small-cap industrial products companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk.

Profitability

This table compares Lakeland Industries and Invacare's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Lakeland Industries18.93%28.75%24.67%
Invacare-4.87%-8.76%-3.07%

Analyst Ratings

This is a summary of recent ratings for Lakeland Industries and Invacare, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Lakeland Industries00203.00
Invacare00103.00

Lakeland Industries currently has a consensus target price of $31.3333, suggesting a potential upside of 11.59%. Invacare has a consensus target price of $17.00, suggesting a potential upside of 105.56%. Given Invacare's higher possible upside, analysts clearly believe Invacare is more favorable than Lakeland Industries.

Institutional and Insider Ownership

70.8% of Lakeland Industries shares are owned by institutional investors. Comparatively, 96.7% of Invacare shares are owned by institutional investors. 4.9% of Lakeland Industries shares are owned by company insiders. Comparatively, 3.2% of Invacare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Lakeland Industries and Invacare's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lakeland Industries$107.81 million2.09$3.28 million$0.4562.40
Invacare$927.96 million0.31$-53,330,000.00($1.06)-7.80

Lakeland Industries has higher earnings, but lower revenue than Invacare. Invacare is trading at a lower price-to-earnings ratio than Lakeland Industries, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Lakeland Industries has a beta of 0.03, suggesting that its share price is 97% less volatile than the S&P 500. Comparatively, Invacare has a beta of 0.94, suggesting that its share price is 6% less volatile than the S&P 500.

Summary

Lakeland Industries beats Invacare on 9 of the 13 factors compared between the two stocks.

Sanara MedTech (NASDAQ:SMTI) and Lakeland Industries (NASDAQ:LAKE) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, earnings, profitability and analyst recommendations.

Valuation & Earnings

This table compares Sanara MedTech and Lakeland Industries' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sanara MedTech$11.77 million20.43$-2,810,000.00N/AN/A
Lakeland Industries$107.81 million2.09$3.28 million$0.4562.40

Lakeland Industries has higher revenue and earnings than Sanara MedTech.

Profitability

This table compares Sanara MedTech and Lakeland Industries' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Sanara MedTech-39.58%-175.36%-55.40%
Lakeland Industries18.93%28.75%24.67%

Risk and Volatility

Sanara MedTech has a beta of 2.43, meaning that its share price is 143% more volatile than the S&P 500. Comparatively, Lakeland Industries has a beta of 0.03, meaning that its share price is 97% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current recommendations for Sanara MedTech and Lakeland Industries, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Sanara MedTech0000N/A
Lakeland Industries00203.00

Lakeland Industries has a consensus price target of $31.3333, suggesting a potential upside of 11.59%. Given Lakeland Industries' higher probable upside, analysts plainly believe Lakeland Industries is more favorable than Sanara MedTech.

Insider and Institutional Ownership

70.8% of Lakeland Industries shares are held by institutional investors. 78.4% of Sanara MedTech shares are held by insiders. Comparatively, 4.9% of Lakeland Industries shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Lakeland Industries beats Sanara MedTech on 9 of the 12 factors compared between the two stocks.

Surgalign (NASDAQ:SRGA) and Lakeland Industries (NASDAQ:LAKE) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.

Risk and Volatility

Surgalign has a beta of 2.21, meaning that its stock price is 121% more volatile than the S&P 500. Comparatively, Lakeland Industries has a beta of 0.03, meaning that its stock price is 97% less volatile than the S&P 500.

Valuation & Earnings

This table compares Surgalign and Lakeland Industries' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgalign$308.38 million0.73$-211,640,000.00($0.16)-12.81
Lakeland Industries$107.81 million2.09$3.28 million$0.4562.40

Lakeland Industries has lower revenue, but higher earnings than Surgalign. Surgalign is trading at a lower price-to-earnings ratio than Lakeland Industries, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Surgalign and Lakeland Industries' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Surgalign-56.07%-101.34%-18.44%
Lakeland Industries18.93%28.75%24.67%

Insider & Institutional Ownership

53.5% of Surgalign shares are owned by institutional investors. Comparatively, 70.8% of Lakeland Industries shares are owned by institutional investors. 3.7% of Surgalign shares are owned by company insiders. Comparatively, 4.9% of Lakeland Industries shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Surgalign and Lakeland Industries, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Surgalign00403.00
Lakeland Industries00203.00

Surgalign currently has a consensus price target of $4.3333, indicating a potential upside of 111.38%. Lakeland Industries has a consensus price target of $31.3333, indicating a potential upside of 11.59%. Given Surgalign's higher possible upside, equities research analysts plainly believe Surgalign is more favorable than Lakeland Industries.

Summary

Lakeland Industries beats Surgalign on 9 of the 13 factors compared between the two stocks.

Surgalign (NASDAQ:SRGA) and Lakeland Industries (NASDAQ:LAKE) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, profitability, valuation and risk.

Institutional & Insider Ownership

53.5% of Surgalign shares are held by institutional investors. Comparatively, 70.8% of Lakeland Industries shares are held by institutional investors. 3.7% of Surgalign shares are held by company insiders. Comparatively, 4.9% of Lakeland Industries shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Risk & Volatility

Surgalign has a beta of 2.21, meaning that its stock price is 121% more volatile than the S&P 500. Comparatively, Lakeland Industries has a beta of 0.03, meaning that its stock price is 97% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and price targets for Surgalign and Lakeland Industries, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Surgalign00403.00
Lakeland Industries00203.00

Surgalign currently has a consensus price target of $4.3333, indicating a potential upside of 111.38%. Lakeland Industries has a consensus price target of $31.3333, indicating a potential upside of 11.59%. Given Surgalign's higher possible upside, analysts clearly believe Surgalign is more favorable than Lakeland Industries.

Earnings and Valuation

This table compares Surgalign and Lakeland Industries' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgalign$308.38 million0.73$-211,640,000.00($0.16)-12.81
Lakeland Industries$107.81 million2.09$3.28 million$0.4562.40

Lakeland Industries has lower revenue, but higher earnings than Surgalign. Surgalign is trading at a lower price-to-earnings ratio than Lakeland Industries, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Surgalign and Lakeland Industries' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Surgalign-56.07%-101.34%-18.44%
Lakeland Industries18.93%28.75%24.67%

Summary

Lakeland Industries beats Surgalign on 9 of the 13 factors compared between the two stocks.

Conformis (NASDAQ:CFMS) and Lakeland Industries (NASDAQ:LAKE) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership and profitability.

Valuation and Earnings

This table compares Conformis and Lakeland Industries' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Conformis$77.43 million2.12$-28,480,000.00($0.44)-2.04
Lakeland Industries$107.81 million2.09$3.28 million$0.4562.40

Lakeland Industries has higher revenue and earnings than Conformis. Conformis is trading at a lower price-to-earnings ratio than Lakeland Industries, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Conformis and Lakeland Industries' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Conformis-32.11%-174.01%-32.59%
Lakeland Industries18.93%28.75%24.67%

Risk & Volatility

Conformis has a beta of 1.63, meaning that its share price is 63% more volatile than the S&P 500. Comparatively, Lakeland Industries has a beta of 0.03, meaning that its share price is 97% less volatile than the S&P 500.

Insider & Institutional Ownership

30.2% of Conformis shares are owned by institutional investors. Comparatively, 70.8% of Lakeland Industries shares are owned by institutional investors. 3.2% of Conformis shares are owned by insiders. Comparatively, 4.9% of Lakeland Industries shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of recent ratings and target prices for Conformis and Lakeland Industries, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Conformis01302.75
Lakeland Industries00203.00

Conformis currently has a consensus target price of $2.3333, indicating a potential upside of 160.07%. Lakeland Industries has a consensus target price of $31.3333, indicating a potential upside of 11.59%. Given Conformis' higher probable upside, equities analysts clearly believe Conformis is more favorable than Lakeland Industries.

Summary

Lakeland Industries beats Conformis on 10 of the 14 factors compared between the two stocks.


Lakeland Industries Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Sientra logo
SIEN
Sientra
1.6$7.17-2.4%$410.65 million$83.70 million-4.03Analyst Upgrade
Invacare logo
IVC
Invacare
1.6$8.27-0.5%$284.69 million$927.96 million-6.72
SMTI
Sanara MedTech
0.8$31.57-1.4%$240.47 million$11.77 million-24.47
Surgalign logo
SRGA
Surgalign
1.7$2.05-5.9%$226.05 million$308.38 million-1.14Analyst Upgrade
Gap Down
Surgalign logo
SRGA
Surgalign
1.4$2.05-5.9%$226.05 million$308.38 million-1.14Analyst Upgrade
Gap Down
Conformis logo
CFMS
Conformis
1.3$0.90-0.0%$163.81 million$77.43 million-2.64News Coverage
ReWalk Robotics logo
RWLK
ReWalk Robotics
1.4$2.13-6.6%$98.18 million$4.87 million-1.69News Coverage
Gap Down
CollPlant Biotechnologies logo
CLGN
CollPlant Biotechnologies
1.1$13.80-0.4%$78.25 million$2.32 million-6.90
Predictive Oncology logo
POAI
Predictive Oncology
1.3$1.49-5.4%$72.70 million$1.41 million-0.24High Trading Volume
Gap Down
AHPI
Allied Healthcare Products
0.5$4.58-3.5%$18.37 million$31.89 million0.00Gap Down
NanoVibronix logo
NAOV
NanoVibronix
0.5$1.00-3.0%$13.39 million$530,000.00-1.67
This page was last updated on 4/10/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.